Skip to main content

Peer Review reports

From: Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder

Original Submission
17 Apr 2020 Submitted Original manuscript
20 Jun 2020 Reviewed Reviewer Report
12 Aug 2020 Reviewed Reviewer Report
4 Sep 2020 Author responded Author comments - Takuya Saito
Resubmission - Version 2
4 Sep 2020 Submitted Manuscript version 2
22 Sep 2020 Author responded Author comments - Takuya Saito
Resubmission - Version 3
22 Sep 2020 Submitted Manuscript version 3
1 Oct 2020 Reviewed Reviewer Report
20 Oct 2020 Author responded Author comments - Takuya Saito
Resubmission - Version 4
20 Oct 2020 Submitted Manuscript version 4
23 Oct 2020 Author responded Author comments - Takuya Saito
Resubmission - Version 5
23 Oct 2020 Submitted Manuscript version 5
Publishing
27 Oct 2020 Editorially accepted
10 Nov 2020 Article published 10.1186/s12888-020-02932-2

You can find further information about peer review here.

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us